Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors --Reference-Cited by-同舟云学术

Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors -

Published:2011 Issue:9 Volume:75 Page:2087-2094
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Okumura Ken¹,Komatsu Takashi²,Yamashita Takeshi³,Okuyama Yuji⁴,Harada Masahiko⁵,Konta Yoshiyuki⁶,Hatayama Toru⁷,Horiuchi Daisuke¹,Tsushima Eiki⁸

Affiliation:

1. Department of Cardiology, Hirosaki University Hospital

2. Department of Cardiology, Iwate Medical University Hospital

3. Department of Cardiovascular Medicine, The Cardiovascular Institute

4. Department of Cardiology, Osaka General Medical Center

5. Department of Cardiology, Ube Industry Central Hospital

6. Department of Internal Medicine, Reimeikyo Rehabilitation Hospital

7. Hatayama Clinic

8. Department of Physical Therapy, Hirosaki University School of Health Science

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/75/9/75_CJ-11-0350/_pdf

Reference23 articles.

1. 1. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.

2. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

3. Guidelines for the management of atrial fibrillation

4. 4. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. Circ J 2010; 74: 2479-2500.

5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Circulation Journal;2022-10-25

2. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Journal of Arrhythmia;2022-10-25

3. Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range;Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology;2021-09-20

4. Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development;Frontiers in Pharmacology;2021-06-09

5. Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation;Frontiers in Pharmacology;2021-04-26